Work

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

Year: 2017

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/bmt.2017.197

Authors: C Cho, M Hsu, P Barba, M A Maloy, S T Avecilla, J N Barker, H Castro-Malaspina, S A Giralt, A A Jakubowski, G Koehne, R C Meagher, R J O’Reilly, E B Papadopoulos, D M Ponce, R Tamari, M R M van den Brink, J W Young, S M Devlin, M-A Perales

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Rockefeller University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Immunobiology of Allogeneic Hematopoietic Cell Transplantation, G4102770861, G4726943279, G9000003249, G9000087764, Cancer Center Support Grant

OpenAlex ID: W2761962041

FWCI: 1.842

Cites: 26

Cited by: 16

Related to: 10